Immunomagnetic assay with microfluidic technology can capture, manipulate circulating

[News]

To quantify rare tumor markers that will allow oncologists to make prognoses and select therapies, John X.J. Zhang, PhD led a team of bioengineers from the Thayer School of Engineering at Dartmouth in demonstrating a novel system that couples nano-engineered particles and microfluidic chips for capturing and manipulating circulating tumor cells (CTCs).

More... (http://www.news-medical.net/news/20150325/Immunomagnetic-assay-with-microfluidic-technology-can-capture-manipulate-circulating-tumor-cells.aspx)